Evidence map›Paper›PMID 28955228›Full record

ArticleFrontiers in pharmacology2017

Alginate Oligosaccharide DP5 Exhibits Antitumor Effects in Osteosarcoma Patients following Surgery.

Jiayu Chen, Yu Hu, Lirong Zhang, Yingjian Wang, Shichao Wang, Yanzi Zhang, Haiyan Guo, Degang Ji, Yingtao Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Advances in alginate biosynthesis: regulation and production inFrontiers in bioengineering and biotechnology · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jiayu ChenDepartment of Basic Medicine, Medical School, Shaoxing UniversityShaoxing, China.
Yu HuDepartment of Pathology, China-Japan Union Hospital of Jilin UniversityChangchun, China.
Lirong ZhangDepartment of Pathology, China-Japan Union Hospital of Jilin UniversityChangchun, China.
Yingjian WangDepartment of Gynecology and Obstetrics, China-Japan Union Hospital of Jilin UniversityChangchun, China.
Shichao WangDepartment of Gynecology and Obstetrics, China-Japan Union Hospital of Jilin UniversityChangchun, China.
Yanzi ZhangWenzhou Medical CollegeWenzhou, China.
Haiyan GuoDepartment of Pathology, Tumor Hospital of Jilin ProvinceChangchun, China.
Degang JiDepartment of Hepatobiliary Pancreatic Surgery, China-Japan Union Hospital of Jilin UniversityChangchun, China.
Yingtao WangPharmacy Department, China-Japan Union Hospital of Jilin UniversityChangchun, China.
Union Hospital · CNShaoxing University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteosarcoma is a malignant musculoskeletal tumor that has high-rate morbidity and mortality worldwide. Alginate oligosaccharide (AOS), a natural product, has antitumor activities and may have therapeutic effects in osteosarcoma, the molecular mechanisms of which remain unclear. AOS was prepared from alginate sodium using alginate lyase. The fractions of AOS were further isolated by size-exclusion chromatography and verified by electrospray ionization mass spectrometry (ESI-MS). Osteosarcoma patients were enrolled in the study and assigned into two groups: AOS (AG, oral administration of 10-mg AOS daily) and control groups (CG, placebo). Preoperative and postoperative clinical data were investigated and analyzed. Four different degrees of polymerizations (DPs) were isolated and denominated as DP2, DP3, DP4, and DP5. Among these polymers, only DP5 showed antitumor functions on osteosarcoma cells. Before surgery and the outcome of primary end point after surgery, no significant differences were observed for clinical data and tumor size between the AG and CG groups (

Indexed as

alginate oligosaccharideanti-inflammatoryantioxidantlocal recurrenceosteosarcomatumor volume

Identifiers

PMID28955228
PMCPMC5600923
OpenAlexW2755273190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.